OTC Markets OTCPK - Delayed Quote USD

Oxford Biomedica plc (OXBDF)

Compare
5.02 0.00 (0.00%)
At close: October 7 at 4:00 PM EDT
Loading Chart for OXBDF
DELL
  • Previous Close 0.00
  • Open 5.00
  • Bid 4.90 x 317000
  • Ask 5.10 x 45100
  • Day's Range 5.00 - 5.00
  • 52 Week Range 2.09 - 5.02
  • Volume 164
  • Avg. Volume 4,801
  • Market Cap (intraday) 532.526M
  • Beta (5Y Monthly) 1.09
  • PE Ratio (TTM) --
  • EPS (TTM) -1.89
  • Earnings Date Sep 23, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

www.oxb.com

834

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OXBDF

View More

Performance Overview: OXBDF

Trailing total returns as of 10/8/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OXBDF
86.58%
FTSE 100
6.16%

1-Year Return

OXBDF
43.40%
FTSE 100
9.54%

3-Year Return

OXBDF
75.21%
FTSE 100
15.99%

5-Year Return

OXBDF
25.09%
FTSE 100
14.06%

Compare To: OXBDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OXBDF

View More

Valuation Measures

Annual
As of 10/7/2024
  • Market Cap

    528.24M

  • Enterprise Value

    566.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.97

  • Price/Book (mrq)

    6.08

  • Enterprise Value/Revenue

    4.43

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -145.98%

  • Return on Assets (ttm)

    -12.67%

  • Return on Equity (ttm)

    -124.66%

  • Revenue (ttm)

    97.28M

  • Net Income Avi to Common (ttm)

    -142.02M

  • Diluted EPS (ttm)

    -1.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    81.41M

  • Total Debt/Equity (mrq)

    154.88%

  • Levered Free Cash Flow (ttm)

    -34.93M

Company Insights: OXBDF

People Also Watch